Robert John Wilkinson
Impact in
- Infectious Diseases top 0.01%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- Epidemiology top 0.05%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 262
- SARS-CoV-2 and COVID-19 Research 20
- Epidemiology 172
- Mycobacterium research and diagnosis 97
- Pneumocystis jirovecii pneumonia detection and treatment 62
- Co-authors
- Katalin Andrea Wilkinson (122 shared papers)Graeme Meintjes (104 shared papers)Gary Maartens (40 shared papers)Adrian Martineau (28 shared papers)Anne O’Garra (11 shared papers)Geoffrey Pasvol (21 shared papers)Molebogeng Xheedha Rangaka (32 shared papers)Robert N. Davidson (13 shared papers)
- Journals
- Clinical Infectious Diseases (31 papers)PLoS ONE (21 papers)Wellcome Open Research (19 papers)The Journal of Infectious Diseases (18 papers)Frontiers in Immunology (15 papers)
- Partner nations
- United KingdomSouth AfricaUnited States
In The Last Decade
Robert John Wilkinson
532 papers receiving 31.2k citations
Robert John Wilkinson's Hit Papers
Peers
Comparison fields: 5 of 197
- Infectious Diseases 18.2k
- Epidemiology 11.3k
- Immunology 5.9k
- Surgery 8.5k
- Microbiology 1.1k
Countries citing papers authored by Robert John Wilkinson
This map shows the geographic impact of Robert John Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert John Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert John Wilkinson more than expected).
Fields of papers citing papers by Robert John Wilkinson
This network shows the impact of papers produced by Robert John Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert John Wilkinson. The network helps show where Robert John Wilkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert John Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 565 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Hit paper breakdown → | 2010 | 1564 |
| 2 | The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Hit paper breakdown → | 2009 | 1153 |
| 3 | The Immune Response in Tuberculosis Hit paper breakdown → | 2013 | 1064 |
| 4 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Hit paper breakdown → | 2019 | 799 |
| 5 | Tuberculous meningitis: a uniform case definition for use in clinical research Hit paper breakdown → | 2010 | 718 |
| 6 | Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study Hit paper breakdown → | 2000 | 654 |
| 7 | Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Hit paper breakdown → | 2008 | 600 |
| 8 | High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial Hit paper breakdown → | 2011 | 491 |
| 9 | Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Hit paper breakdown → | 2015 | 479 |
| 10 | T cell responses to SARS-CoV-2 spike cross-recognize Omicron Hit paper breakdown → | 2022 | 458 |
| 11 | Final Analysis of a Trial of M72/AS01 E Vaccine to Prevent Tuberculosis Hit paper breakdown → | 2019 | 416 |
| 12 | Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis Hit paper breakdown → | 2011 | 406 |
| 13 | 2001 | 375 | |
| 14 | Tuberculous meningitis Hit paper breakdown → | 2017 | 363 |
| 15 | 2008 | 358 | |
| 16 | 2007 | 358 | |
| 17 | 2007 | 351 | |
| 18 | 2010 | 328 | |
| 19 | 2007 | 323 | |
| 20 | Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis Hit paper breakdown → | 2018 | 320 |
About Robert John Wilkinson
Robert John Wilkinson is a scholar working on Infectious Diseases, Epidemiology, Surgery, Immunology and Microbiology, having authored 565 papers that have together received 32.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (262 papers), Infectious Diseases and Tuberculosis (126 papers), Mycobacterium research and diagnosis (97 papers), Pneumocystis jirovecii pneumonia detection and treatment (62 papers), Vitamin D Research Studies (24 papers), Diagnosis and treatment of tuberculosis (21 papers), Bacterial Infections and Vaccines (21 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). The work is most often cited by research in Infectious Diseases (18.2k citations), Epidemiology (11.3k citations), Immunology (5.9k citations), Surgery (8.5k citations) and Microbiology (1.1k citations). Robert John Wilkinson has collaborated with scholars based in United Kingdom, South Africa and United States. Frequent co-authors include Katalin Andrea Wilkinson, Graeme Meintjes, Gary Maartens, Adrian Martineau, Anne O’Garra, Geoffrey Pasvol, Molebogeng Xheedha Rangaka, Robert N. Davidson, Clifton E. Barry and Paul S. Redford. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, Wellcome Open Research, The Journal of Infectious Diseases and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.